General Information of Target

Target ID LDTP02082
Target Name Interleukin-5 (IL5)
Gene Name IL5
Gene ID 3567
Synonyms
Interleukin-5; IL-5; B-cell differentiation factor I; Eosinophil differentiation factor; T-cell replacing factor; TRF
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MRMLLHLSLLALGAAYVYAIPTEIPTSALVKETLALLSTHRTLLIANETLRIPVPVHKNH
QLCTEEIFQGIGTLESQTVQGGTVERLFKNLSLIKKYIDGQKKKCGEERRRVNQFLDYLQ
EFLGVMNTEWIIES
Target Type
Successful
Target Bioclass
Cytokine and receptor
Family
IL-5 family
Subcellular location
Secreted
Function
Homodimeric cytokine expressed predominantly by T-lymphocytes and NK cells that plays an important role in the survival, differentiation, and chemotaxis of eosinophils. Acts also on activated and resting B-cells to induce immunoglobulin production, growth, and differentiation. Mechanistically, exerts its biological effects through a receptor composed of IL5RA subunit and the cytokine receptor common subunit beta/CSF2RB. Binding to the receptor leads to activation of various kinases including LYN, SYK and JAK2 and thereby propagates signals through the RAS-MAPK and JAK-STAT5 pathways respectively.
TTD ID
T78585
Uniprot ID
P05113
DrugMap ID
TTPREZD
Ensemble ID
ENST00000231454.6
HGNC ID
HGNC:6016
ChEMBL ID
CHEMBL1169600

Probe(s) Labeling This Target

ABPP Probe
Click To Hide/Show 1 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
IPM
 Probe Info 
N.A.  LDD0241  [1]

The Interaction Atlas With This Target

The Protein(s) Related To This Target

Cytokine and receptor
Click To Hide/Show 2 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Cytokine receptor common subunit beta (CSF2RB) Type I cytokine receptor family P32927
Interleukin-5 receptor subunit alpha (IL5RA) Type I cytokine receptor family Q01344

The Drug(s) Related To This Target

Approved
Click To Hide/Show 3 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Benralizumab Monoclonal antibody D02PIO
Mepolizumab Monoclonal antibody D03MTN
Reslizumab Monoclonal antibody D0O8KX
Investigative
Click To Hide/Show 2 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Pranlukast Small molecular drug DB01411
Sophoricoside Small molecular drug D07CEU

References

1 Oxidant-Induced Bioconjugation for Protein Labeling in Live Cells. ACS Chem Biol. 2023 Jan 20;18(1):112-122. doi: 10.1021/acschembio.2c00740. Epub 2022 Dec 21.